Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReact Group Regulatory News (REAT)

Share Price Information for React Group (REAT)

Share Price is delayed by 15 minutes
Get Live Data
45.50    0.00 (0.00%)
Bid:
44.00
Ask:
47.00
Spread: 3.00 (6.818%)
Market Cap: £10.75m
REAT Live PriceLast checked at - London Stock Exchange

Intraday React Group Share Chart

Trading Update

6 Apr 2020 07:00

RNS Number : 8172I
React Group PLC
06 April 2020
Β 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Β 

REACT Group PLC

Β 

("REACT" or the "Company")

Β 

REACT Group Plc., (AIM: REAT.L) the leading specialist cleaning and decontamination company, provides the following market update.

Β 

The REACT business is experiencing high demand to provide decontamination and infection control services, including the thorough deep cleaning of premises thought be harbouring SARS-CoV-2, the virus responsible for CV-19 (2019 novel coronavirus/COVID-19).

Β 

REACT provides a rapid response to the threat posed by CV-19, applying high standards of deep cleaning and testing to enable Customers to return potentially infected properties to safe operational use, alongside providing reassurance to the people that use or pass through them.

Β 

Making use of some proprietary components our methodology eliminates all traces of the virus, applies onsite ATP testing to confirm and certify a site is clear and equips our specialist cleaning operators beyond recommended standards to ensure their health and safety.

Β 

REACT has expanded capacity to support demand by cross training our experienced operators and through partnerships and sub-contracting with smaller specialist cleaning operators.

Β 

REACT has entered into a number of agreements with Tier 1 Customers to provide a 'first-response' service to support multiple premises in England and Wales. Although we anticipate the rate of demand softening over the next few weeks as the impact of the lock-down reduces incidents requiring remedial action, we believe demand for deep cleaning and decontamination will increase again as the country returns, albeit in stages, to some form of normality.

Β 

The REACT business is divided into two-parts of approximately equal size of revenues; reactive cleaning services - which is supporting the deep cleaning requirements; and regular maintenance services. The regular maintenance business largely operates in the Healthcare, Road and Rail sectors, all of which have yet to see material changes to operations. Whilst at present we anticipate any reduction in activity in one sector will be counter-balanced by demand in another, it is too early to reliably forecast the impact of any sustained period of economic disruption on our underlying business.

Β 

At the start of the financialΒ year, which runs to 30 September 2020, managementΒ expectations had been for the business to move into profitability after reporting annual losses for the last four-years. RecentΒ trading, notablyΒ in March, has been ahead of management expectations and as result the Group is likely to have delivered a small operatingΒ profit in the six months to 31 March 2020, whichΒ puts the Group in a good position to meet or exceed managementΒ expectations for the full year.

Β 

The health and welfare of all our colleagues is paramount; for those not in front-line services, such as sales and administration, we took the early decision to put in place policies and procedures to enable remote working in early March 2020.

Β 

Management are using all tools at its disposal to preserve cash, focusing on secure revenue streams with high quality Customers, deferring non-critical capital expenses and using government-backed support initiatives where appropriate.

Β 

The (unaudited) cash balances at 31 March 2020 amounted to c.Β£306,000. This includes only one week's worth of payments from the c. Β£0.5 million Tier 1 Customer contract announced via RNS on 23 January 2020, and which has until this point consumed cash. The cashflow remittances from this Contract, which is continuing to perform very well, are weekly from this point onwards and will contribute positively to the Company's cash position. In addition, REACT has negotiated with a bank an initial line of credit of Β£225,000 on favourable terms secured through invoice discounting. We therefore believe we are in a strong position to support growth in key areas of the business.

Β 

In summary, the Company is facing opportunities and challenges, the scale and nature of which is constantly changing and, as yet, we have no clear visibility of its likely duration. We will further update the market once we have the information to credibly do so, in the meantime management continues to closely monitor the situation regarding CV-19 and remains confident in the continued performance and flexibility of the Group to deliver for its Clients.

Β 

The Company expects to publish its half year report for the six months ended 31 March 2020 in June 2020.

Β 

REACT Group PLC

Shaun Doak - Chief Executive Officer

Β 

Β 

0772 500 3662

SPARK Advisory Partners Limited

Neil Baldwin / Henry Todd

Β 

0113 370 8974

Peterhouse Capital (Broker)

Duncan Vasey/Martin Lampshire

0207 459 0930

Β 

Β 

Note to Editors:

The official names for the virus responsible for COVID-19 (previously known as '2019 novel coronavirus') and the disease it causes are:

Β 

Disease:

Coronavirus disease (COVID-19)

Β 

Virus:

SARS-CoV-2

Β 

ATP testing is the process of rapidly measuring actively growing micro-organisms through detection of adenosine triphosphate - REACT use ATP testing to confirm swabbed areas have been cleared of pathogens, i.e. decontamination has removed the presence of SARS-CoV-2.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
UPDEANLSEEFEEFA
Date   Source Headline
17th Jun 202611:56 amRNSDirector/PDMR Shareholding
19th May 202611:23 amRNSInvestor Presentation via Investor Meet Company
19th May 20267:00 amRNSInterim Results and Investor Presentation
13th May 20265:17 pmRNSDirector/PDMR Shareholding
15th Apr 202610:25 amRNSDirector/PDMR Shareholding
31st Mar 20267:28 amRNSAGM Statement
27th Mar 202610:16 amRNSNotice of AGM
13th Feb 20264:22 pmRNSHolding(s) in Company
13th Feb 20264:13 pmRNSHolding(s) in Company
13th Feb 20263:03 pmRNSDirector/PDMR Shareholding
13th Feb 20261:11 pmRNSDirector/PDMR Shareholding
12th Feb 20265:18 pmRNSHolding(s) in Company
12th Feb 202611:35 amRNSHolding(s) in Company
11th Feb 20264:18 pmRNSHolding(s) in Company
10th Feb 20264:33 pmRNSPDMR Dealings
5th Feb 20267:00 amRNSFinal Results
2nd Feb 20267:00 amRNSNotice of Results
19th Jan 20263:37 pmRNSHolding(s) in Company
13th Jan 20262:56 pmRNSDirector/PDMR Shareholding
9th Jan 20263:03 pmRNSHolding(s) in Company
2nd Jan 202611:15 amRNSDirector/PDMR Shareholding
15th Dec 20254:28 pmRNSDirector/PDMR Shareholding
14th Nov 20253:43 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Update
16th Oct 20255:18 pmRNSDirector/PDMR Shareholding
16th Sep 20259:13 amRNSDirector/PDMR Shareholding
14th Aug 202511:31 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSContract Wins
16th Jul 20252:38 pmRNSShare Incentive Plan
15th Jul 20251:53 pmRNSHolding(s) in Company
27th May 20257:00 amRNSInterim Results & Trading Update
19th May 20258:27 amRNSHolding(s) in Company
29th Apr 202512:30 pmRNSHolding(s) in Company
25th Apr 20252:35 pmRNSHolding(s) in Company
27th Mar 20251:15 pmRNSResult of AGM
27th Mar 20257:00 amRNSAGM Statement
19th Mar 20253:01 pmRNSDirector/PDMR Shareholding
19th Mar 20251:15 pmRNSHolding(s) in Company
6th Mar 202512:09 pmRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSNotice of AGM
12th Feb 20253:34 pmRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNS-RContract Win
30th Jan 20251:59 pmRNSHolding(s) in Company
29th Jan 202511:11 amRNSInvestor Presentation
29th Jan 20257:00 amRNSFinal Results
28th Jan 20256:07 pmRNSHolding(s) in Company
21st Jan 20252:00 pmRNSHolding(s) in Company
8th Nov 20245:12 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSExercise of Options & Total Voting Rights
30th Oct 20243:09 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.